Pathogenesis and Treatment of Biliopancreatic Cancer
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 564
Special Issue Editor
Special Issue Information
Dear Colleagues,
Biliopancreatic cancers, including pancreatic cancers, cholangiocarcinoma, and gallbladder cancer, occur with an increasing incidence, with a large proportion accounting for fatalities related to metastatic disease.
This Special Issue on “Pathogenesis and Treatment of Biliopancreatic Cancer” aims to publish cutting-edge research on both preclinical and clinical studies on these cancers, including a comprehensive overview of tumor progression in association with the tumor microenvironment, metastatic process, cancer treatment, immune response, or drug resistance.
In the evolving landscape of oncological research, understanding the genetic and epigenetic alterations that underpin these cancers is crucial. We are particularly keen on submissions that explore the latest advancements in diagnostic tools, predictive biomarkers, and personalized treatment approaches. The intricate dance between cancer cells and the immune system, especially in the context of emerging immunotherapies, is another area of profound interest.
Review articles as well as original studies will be considered for publication. We hope that both academics and clinics working on gastrointestinal cancer will find this platform useful. We look forward to receiving exceptional submissions.
Prof. Dr. Antonio Benedetti
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biliopancreatic cancers
- tumor microenvironment
- metastatic process
- immunotherapy
- drug resistance
- diagnostic biomarkers
- personalized treatment
- genetic alterations
